Why Chemed Stock Is Plummeting Today
(NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Chemed reported second-quarter earnings that fell short of analysts' expectations, causing its share price to tumble.
While Chemed grew sales by 4% in Q2, adjusted earnings per share (EPS) declined by a staggering 22%. Meanwhile, management cut 2025 EPS guidance from $25.20 to $22.15, implying a 4% decline from last year's earnings.
Source Fool.com
Chemed Corp. Aktie
?
-0,52 %
Deutliche Buy-Präferenz bei Chemed Corp. ohne Sell-Einschätzungen.
Ein Kursziel von 515 € für Chemed Corp. signalisiert eine potenzielle Steigerung von über 20% gegenüber dem aktuellen Kurs von 380.0 €.
